Posted On: 11/15/2013 7:20:45 AM
Post# of 72445
It's Report Card time and I'm handing out my CTIX grades for 2014 through the first three quarters:
Dr Menon: B+ (Positive: Kevetrin trials at DF/Beth Israel, MD Anderson and U of B agreements. Negative: Prurisol, does it have a future? What you need to focus on: Kevetrin, Kevetrin, Kevetrin . . . Prurisol future and making Brilacidin actually work without crazy side effects.
Leo: C+ (Positive: Picking Dr Menon to be your "lab partner." Securing financing with Aspire. Negative: Over-hyping your PR's and creating undo shareholder expectations. No Board of Directors. Jury is still out on: Polymedix purchase. What you need to focus on: Kevetrin, Kevetrin, Kevetrin and a partnership deal for B (if it works). Creating a BOD. Finding at least 3 institutional investors who purchase a combined minimum of 10 million shares.
Dr Menon: B+ (Positive: Kevetrin trials at DF/Beth Israel, MD Anderson and U of B agreements. Negative: Prurisol, does it have a future? What you need to focus on: Kevetrin, Kevetrin, Kevetrin . . . Prurisol future and making Brilacidin actually work without crazy side effects.
Leo: C+ (Positive: Picking Dr Menon to be your "lab partner." Securing financing with Aspire. Negative: Over-hyping your PR's and creating undo shareholder expectations. No Board of Directors. Jury is still out on: Polymedix purchase. What you need to focus on: Kevetrin, Kevetrin, Kevetrin and a partnership deal for B (if it works). Creating a BOD. Finding at least 3 institutional investors who purchase a combined minimum of 10 million shares.
(0)
(0)
